Global Particle Therapy Market Size Worth USD 1.46 Billion by 2032 | CAGR of 8.1%
Category: HealthcareGlobal Particle Therapy Market Size Worth USD 1.46 Billion by 2032
According to a research report published by Spherical Insights & Consulting, The Global Particle Therapy Market size is to grow from USD 0.67 billion in 2022 to USD 1.46 billion by 2032, at a Compound Annual Growth Rate CAGR of 8.1% during the forecast period.
Get more details on this report -
Browse key industry insights spread across 200 pages with 120 market data tables and figures & charts from the report on the "Global Particle Therapy Market Size, Share, and COVID-19 Impact Analysis, By type (Proton Therapy and Heavy Ion Therapy), By System (Multi-Room Systems and Single-Room Systems), By Cancer Type (Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Head and Neck Cancer, and Others), By Application (By App Treatment and Research), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/particle-therapy-market
Particle therapy, a cutting-edge form of cancer treatment, employs charged particles like protons and heavy ions for precise tumor targeting. By delivering energy directly to cancerous tissues while minimizing damage to surrounding healthy cells, particle therapy minimizes side effects and enhances treatment efficacy. Its modulated energy deposition curve and superior dose distribution make it especially effective for complex tumors, pediatric cases, and radioresistant cancers. Despite cost and facility requirements limiting widespread adoption, particle therapy holds immense potential in revolutionizing oncological care by improving patient outcomes and quality of life during and after treatment.
In 2022, the proton therapy segment accounted for around 65.7% market share
On the basis of the type, the global particle therapy market is segmented into proton therapy and heavy ion therapy. The proton therapy segment has emerged as the dominant force in the particle therapy market. This is primarily due to its precise and targeted approach in treating various cancers, minimizing damage to surrounding healthy tissues. Proton therapy's superior dose distribution and reduced long-term side effects make it an attractive option, particularly for pediatric cases and complex tumors.
The single-room systems segment is expected to grow at a higher CAGR of around 8.5% during the forecast period
Based on the system, the global particle therapy market is segmented into multi-room systems and single-room systems. The single-room systems segment is anticipated to experience robust growth within the particle therapy market. This projection can be attributed to their cost-effectiveness and compact design, making them more accessible for healthcare facilities with limited space and resources. As technological advancements continue to improve the efficiency and capabilities of single-room systems, their appeal is growing.
The pediatric cancer segment is grow at a fastest CAGR of around 8.7% during the forecast period
Based on the type of cancer, the global particle therapy market is segmented into pediatric cancer, prostate cancer, lung cancer, breast cancer, head and neck cancer, and others. The pediatric cancer segment is poised to exhibit the fastest growth during the forecast period within the particle therapy market. This accelerated expansion is primarily due to the heightened awareness of the long-term risks associated with traditional radiation therapy in children. Particle therapy's precision in targeting tumors minimizes harm to developing tissues, reducing the potential for adverse effects later in life.
The research segment held the largest market with more than 70.4% revenue share in 2022
Based on the application, the global particle therapy market is segmented into by app treatment and research. The research segment has established its dominance in the particle therapy market, primarily owing to the continuous advancements and studies aimed at enhancing treatment efficacy. Research initiatives focusing on refining particle therapy techniques, expanding its applications, and accumulating clinical evidence have contributed to the segment's prominence. As ongoing studies uncover new insights into particle therapy's potential benefits for various cancers and patient populations, investments in research continue to drive innovation, making the research segment the largest contributor to the overall growth of the particle therapy market.
Europe is predicted to grow at a significant CAGR over the projected period
Get more details on this report -
Based on region, Europe is expected for substantial growth in the particle therapy market during the forecast period. This projection stems from factors such as increasing awareness about advanced cancer treatments, a rising geriatric population susceptible to cancer, and robust healthcare infrastructure. European countries' proactive approach towards adopting innovative medical technologies, coupled with favorable reimbursement policies, is anticipated to drive the expansion of particle therapy facilities.
Asia-Pacific region has dominated by capturing the largest market share. This prominence can be attributed to several factors, including a rising prevalence of cancer cases, increasing healthcare investments, and advancements in medical technology across countries in the region. Moreover, the presence of densely populated countries with a growing demand for advanced cancer treatments, coupled with supportive government initiatives and collaborations with global healthcare leaders.
Some of the major players in the global particle therapy market include IBA Worldwide, Varian Medical Systems, Inc., Hitachi, Ltd., Mevion Medical Systems, Optivus Proton Therapy, Inc., ProTom International, Danfysik A/S, Elekta AB, Provision Healthcare, and Sumitomo Heavy Industries, Ltd.
Key Target Audience
- Market Players
- Investors
- End-Users
- Government Authorities
- Consulting and Research Firm
- Venture Capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In April 2021, Collaboration between IBA Worldwide (EU) and Tractebel (US). This collaboration agreement will assist IBA's clients with proton therapy design and construction projects.
- In May 2022, Mevion Medical Systems has been chosen to install a MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) in a Southern Chinese comprehensive hospital.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global particle therapy market based on the below-mentioned segments:
Particle Therapy Market, By type
- Proton Therapy
- Heavy Ion Therapy
Particle Therapy Market, By System
- Multi-Room Systems
- Single-Room Systems
Particle Therapy Market, By Cancer Type
- Pediatric Cancer
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Head and Neck Cancer
- Others
Particle Therapy Market, By Application
- By App Treatment
- Research
Particle Therapy Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?